MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Drug-induced parkinsonism(DIP)"

  • 2019 International Congress

    Neuromodulatory potentials of revasterol and Carpogon capitatus Roxb on the rat brain: Novel approach for Parkinson’s diseases

    DS. Singh, MS. Singh, PK. Kumar, YK. Gupta (Allahabad, India)

    Objective: The aim of the current study is to explore the synergistic effects of revasterol and Carpogon capitatus extract  Roxb in rotenone induced rat model…
  • 2019 International Congress

    “UPDRS-meter” – a digital and automatic UPDRS scoring application

    Z. Yekutieli, S. Baer-Hassin, V. Livneh, T. Fay-Karmon, S. Israeli-Korn, G. Yahalom (Zichron Yaakov, Israel)

    Objective: To assess the feasibility of a smartphone-based application for performing a motor test that will provide an accurate UPDRS score. Background: Parkinson’s Disease (PD)…
  • 2019 International Congress

    A Case of Pregabalin induced Parkinsonism

    BC. Ari, F. Mayda Domac, G. Ozgen Kenangil (Istanbul, Turkey)

    Objective: Present a case of parkinsonism after administration of pregabalin, a rare case Background: Drug induced parkinsonism is the second common movement disorders after Parkinson’s…
  • 2019 International Congress

    Protective and therapeutic activity of Cinnamaldehyde in the mouse model of Parkinson’s disease

    S. Rajput, S. Sinha (New Delhi, India)

    Objective: Objective of our study was to evaluate protective and therapeutic activity of Cinnamaldehyde in the mouse model of Parkinson’s disease. Background: Parkinson’s disease (PD),…
  • 2019 International Congress

    Drug-Induced Parkinsonism May Persist Beyond Two Years After Discontinuation of Dopamine Transmission Blocking Agents

    J. Randhawa, R. Mehanna (Houston, TX, USA)

    Objective: To demonstrate that patients with drug-induced parkinsonism (DIP) can remain symptomatic beyond 6 months, what majority of literature suggests, after withdrawal of causative agents.…
  • 2019 International Congress

    Re-emerging Neuroleptic Malignant Syndrome (NMS) without Re-introduced Neuroleptic in a Schizophrenia Patient: a Case Report

    D. Tunjungsari, A. Tiksnadi (Jakarta, Indonesia)

    Objective: To report a case with re-emerging neuroleptic malignant syndrome (NMS) without re-introduced neuroleptic drugs. Background: Neuroleptic Malignant Syndrome (NMS) is a potentially fatal idiosyncratic…
  • 2018 International Congress

    Effect of exercise on neurodegenerative parkinsonism unmasked by dopamine blocking drugs (DRBD)

    J. Morley, S. Wood, G. Cheng, K. Browne, K. Robinson, D. Weintraub, J. Duda (Philadelphia, PA, USA)

    Objective: To test whether aerobic walking influences clinical status, biochemical and radiologic markers associated with degenerative parkinsonism unmasked by DRBD. Background: Failed trials of putative…
  • 2018 International Congress

    Parkinson’s Disease Risk in Breast Cancer

    R. Mills-Joseph (Columbus, OH, USA)

    Objective: Case report of two patients who developed symptoms of Parkinson’s disease after treatment with chemotherapy and radiation for breast cancer and to review the…
  • 2018 International Congress

    Rotenone model of Parkinson’s disease: The dosing options in mice revisited

    M. Raza, N. Zehra, S. Malhi (Karachi, Pakistan)

    Objective: In the present study we have used various dosing protocols to induce the PD-like symptoms with the administration of rotenone in mice. Background: Parkinson's…
  • 2018 International Congress

    Diagnostic Impact of Movement Disorders Subspecialty Consultations at a VA Hospital

    B. Barton (Chicago, IL, USA)

    Objective: Review the impact of subspecialty care on diagnosis patterns of patients with parkinsonism at the Jesse Brown VA (JBVA), a VA Consortium center. Background:…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley